Vimarsana
Biggest News Aggregation in the World

Chris Boshoff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chris Boshoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chris Boshoff Today - Breaking & Trending Today

Pfizer : Showcases New Data Across its Broadened Oncology Portfolio at ASCO Annual Meeting - Vimarsana News

Pfizer : Showcases New Data Across its Broadened Oncology Portfolio at ASCO Annual Meeting

Pfizer Showcases New Data Across its Broadened Oncology Portfolio at ASCO Annual Meeting Wednesday, May 29, 2024 - 12:30pm ...

Pfizer (PFE) Q1 2024 Earnings Call Transcript - Vimarsana News

Pfizer (PFE) Q1 2024 Earnings Call Transcript

PFE earnings call for the period ending March 31, 2024.

Source: fool.com
Stock Market Today: Gloomy Start to May Ahead of Fed Decision - Vimarsana News

Stock Market Today: Gloomy Start to May Ahead of Fed Decision

U.S. futures are down as a busy earnings season continues and investors await an interest rate decision from the Fed.

Pfizer (PFE) Q1 2024 Earnings Call Transcript - Vimarsana News

Pfizer (PFE) Q1 2024 Earnings Call Transcript

PFE earnings call for the period ending March 31, 2024.

Source: yahoo.com
Pfizer's TIVDAK® Receives Full FDA Approval for Treating Recurrent or Metastatic Cervical Cancer – India Education | Latest Education News | Global Educational News - Vimarsana News

Pfizer's TIVDAK® Receives Full FDA Approval for Treating Recurrent or Metastatic Cervical Cancer – India Education | Latest Education News | Global Educational News

Pfizer Inc. (NYSE: PFE) and Genmab A/S (Nasdaq: GMAB) today announced the U.S. Food and Drug Administration (FDA) approves the supplemental Biologics License Application (sBLA) granting full approval for TIVDAK® (tisotumab vedotin-tftv) for the treat